ENTRY       D00746                      Drug
NAME        Interferon beta-1b (USAN/INN);
            Interferon beta-1b (genetical recombination) (JAN);
            Betaseron (TN);
            Extavia (TN)
PRODUCT     BETASERON (Bayer HealthCare Pharmaceuticals)
            EXTAVIA (Novartis Pharmaceuticals Corporation)
FORMULA     C903H1399N245O252S5
EXACT_MASS  19867.2792
MOL_WEIGHT  19879.5855
SEQUENCE    SYNLLGFLQR SSNFQSQKLL WQLNGRLEYC LKDRMNFDIP EEIKQLQQFQ KEDAALTIYE
            MLQNIFAIFR QDSSSTGWNE TIVENLLANV YHQINHLKTV LEEKLEKEDF TRGKLMSSLH
            LKRYYGRILH YLKAKEYSHC AWTIVRVEIL RNFYFINRLT GYLRN
  TYPE      Peptide
CLASS       Immunological agent
             DG01752  Interferone
REMARK      Therapeutic category: 6399
            ATC code: L03AB08
            Chemical structure group: DG01751
            Product (DG01751): D00746<JP/US> D03304<JP> D04554<JP/US>
EFFICACY    Immunomodulator, Biological response modifier
  DISEASE   Multiple sclerosis [DS:H01490]
TARGET      IFNAR1 [HSA:3454] [KO:K05130]
            IFNAR2 [HSA:3455] [KO:K05131]
  PATHWAY   hsa04060(3454+3455)  Cytokine-cytokine receptor interaction
            hsa04620(3454+3455)  Toll-like receptor signaling pathway
            hsa04630(3454+3455)  JAK-STAT signaling pathway
            hsa04650(3454+3455)  Natural killer cell mediated cytotoxicity
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L03 IMMUNOSTIMULANTS
               L03A IMMUNOSTIMULANTS
                L03AB Interferons
                 L03AB08 Interferon beta-1b
                  D00746  Interferon beta-1b (USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Central Nervous System Agents
              Multiple Sclerosis Agents
               Interferon Beta-1b
                D00746  Interferon beta-1b (USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             6  Agents against pathologic organisms and parasites
              63  Biological preparations
               639  Miscellaneous
                6399  Others
                 D00746  Interferon beta-1b (USAN/INN); Interferon beta-1b (genetical recombination) (JAN)
            Drug groups [BR:br08330]
             Immunological agent
              DG01752  Interferone
               DG01751  Interferon beta
                D00746  Interferon beta-1b
            Drug classes [BR:br08332]
             Immunological agent
              DG01752  Interferone
               D00746  Interferon beta-1b
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               Interferon receptors
                IFNAR1
                 D00746  Interferon beta-1b (USAN/INN) &lt;JP/US&gt;
                IFNAR2
                 D00746  Interferon beta-1b (USAN/INN) &lt;JP/US&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D00746
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D00746
            Drug groups [BR:br08330]
             Immunological agent
              DG01752  Interferone
               DG01751  Interferon beta
DBLINKS     CAS: 145155-23-3
            PubChem: 7847811
            ChEBI: 5938
///
